Your browser doesn't support javascript.
loading
Case report: Camrelizumab associated with central retinal vein occlusion.
Zhan, Yixiang; Zhao, Weipeng; Ni, Kemin; Liu, Zhaoce; Su, Yanjun; Li, Xichuan; Zhang, Heng; Zhang, Chunze.
Afiliação
  • Zhan Y; Department of Colorectal Surgery, Tianjin Union Medical Center, Tianjin, China.
  • Zhao W; School of Medicine, Nankai University, Tianjin, China.
  • Ni K; Department of Breast Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
  • Liu Z; Department of Colorectal Surgery, Tianjin Union Medical Center, Tianjin, China.
  • Su Y; School of Medicine, Nankai University, Tianjin, China.
  • Li X; Department of Colorectal Surgery, Tianjin Union Medical Center, Tianjin, China.
  • Zhang H; School of Medicine, Nankai University, Tianjin, China.
  • Zhang C; Department of Lung Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Front Immunol ; 13: 1025125, 2022.
Article em En | MEDLINE | ID: mdl-36505454

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oclusão da Veia Retiniana / Melanoma Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oclusão da Veia Retiniana / Melanoma Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article